The Scientific Review Committee (SRC) charter is to review the safety data from the patients treated in the Phase I portion ...

Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5 BOCA RATON, Fla, Feb. 12, 2025 (GLOBE NEWSWIRE) -- INmune Bio ...

On June 2, 2024, Caribou issued a press release announcing that it had "presented updated clinical data from the ongoing ANTLER Phase 1 trial that [purportedly] indicates a single dose of CB-010 . . .

If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal ...

The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. . Shareholders who purchased shares ...

Shares of Nkarta, Inc. (NASDAQ:NKTX – Get Free Report) have been assigned a consensus rating of “Buy” from the seven ...

Caribou Biosciences faces a class action lawsuit by Levi & Korsinsky over misleading statements about CB-010 and financial ...

The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. . Shareholders who purchased shares ...

Our research team assigns Silver ratings to strategies ... Dimensional Fund Advisors treats real estate securities differently than it does other stocks. The firm normally favors companies with ...

Based on its research, Congress passed the Securities Act of 1933, followed by the Securities Exchange Act of 1934, the latter of which established the SEC. As of February 2025, the SEC is run by ...